In tumor types with frequent FADD amplification, such as head and neck cancer, it has been suggested that combined treatment with SMAC mimetics (Birinapant) and radiation may be particularly useful as FADD is key in sensitization to cell death [16]. This evidence concerns the gene FADD and head and neck cancer.